*  Subunit Vaccines Market To Experience Robust Growth Driven By Rising Demand For Treating Infectious Disease, Cancer And...
... subunit, conjugate, and so on. Subunit vaccines are vaccines that use only part of the disease-causing virus.Subunit vaccines, ... polysaccharide vaccine and conjugate subunit vaccine. Protein based subunit vaccines present an antigen to the immune system ... www.millioninsights.com/industry-reports/subunit-vaccines-market/request-sample. This report studies Subunit Vaccines in Global ... Conjugate subunit vaccines, can therefore prevent common bacterial infections for which plain polysaccharide vaccines are ...
  http://www.pennsylvania-magazine.com/story/150036/subunit-vaccines-market-to-experience-robust-growth-driven-by-rising-demand-for-treating-infectious-disease-cancer-and-allergies-till-2021-million-insights.html
*  Vaccines | Free Full-Text | Micelle-Based Adjuvants for Subunit Vaccine Delivery
... antigen delivery systems have been identified as an innovative strategy to improve the efficacy of subunit vaccines. Among them ... we report on the recent research findings highlighting the versatility and potential of such systems in vaccine delivery. ... In the development of subunit vaccines with purified or recombinant antigens for cancer and infectious diseases, the design of ... Vaccines 2015, 3, 803-813. AMA Style. Trimaille T, Verrier B. Micelle-Based Adjuvants for Subunit Vaccine Delivery. Vaccines. ...
  http://www.mdpi.com/2076-393X/3/4/803
*  Isolation and Characterization of a Shigella flexneri Invasin Complex Subunit Vaccine
... invaplex vaccines in guinea pigs or mice is comparable to that generated by live attenuated vaccines or other subunit vaccines ... Delivering subunit vaccines by the mucosal route (intranasal, oral, etc) is difficult and not very effective unless suitable ... Isolation and Characterization of a Shigella flexneri Invasin Complex Subunit Vaccine. K. Ross Turbyfill, Antoinette B. Hartman ... Such vaccines include live attenuated vaccines (25, 32) and delivery of Shigella LPS or O polysaccharides with carriers such as ...
  http://pubmedcentralcanada.ca/pmcc/articles/PMC97759/?lang=en-ca
*  Engineering blend particle delivery platform for subunit vaccines against mucosally transmitted viral infections
... ... This pH-responsive blend particle system represents a simple and promising delivery platform for subunit vaccine development ... The key aspect of a vaccine delivery platform is to be easily programmed towards different antigens and adjuvants application. ... Lacking sufficient immunity, candidate HSV-2 vaccines that were protective in animal model, however, have not been successful ...
  https://digital.lib.washington.edu/researchworks/handle/1773/26166
*  Subunit vaccine design against pathogens causing atherosclerosis
... Infections by opportunistic bacteria have significant ... 2014). Genome-based approaches to develop epitope-driven subunit vaccines against pathogens of infective endocarditis. Journal ... UvrA system protein A as common vaccine candidate. UvrA protein was also reported as vaccine candidate in E. coli (Grossman et ... 2013). T-cell vaccine design for Streptococcus pneumoniae: an in silico approach. Journal of Biomolecular Structure and ...
  http://www.jbsdonline.com/subunit-vaccine-design-against-pathogens-causing-atherosclerosis-p18734.html
*  HIV related peptides, immunogenic antigens, and use therefor as subunit vaccine for AIDS virus - Viral Technologies Inc.
Vaccines effective in the inhibition of infection caused by the family of retroviruses, HTLV-III, Human T-Cell Leukemia Virus, ... HIV related peptides, immunogenic antigens, and use therefor as subunit vaccine for AIDS virus ... When used as a vaccine in the method of this invention, the vaccine can be introduced into the host most conveniently by ... Therefore, the vaccines of this invention can be used to immunize patients at risk for AIDS, or exposed to the AIDS virus or to ...
  http://www.freepatentsonline.com/4983387.html
*  VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines | BMC Bioinformatics | Full Text
Vaccine development in the post-genomic era often begins with the in silico screening of genome information, with the most ... Subunit vaccines contain one or more pure or semi-pure antigens. In order to develop subunit vaccines, it is critical to ... Vaccines from the pre-genomic era were based on killed or live, but attenuated, microorganisms, or subunits purified from them ... Such antigens form the basis of subunit vaccines. In order to facilitate the use of the derived models, a server, named VaxiJen ...
  https://bmcbioinformatics.biomedcentral.com/articles/10.1186/1471-2105-8-4
*  The American Journal of Tropical Medicine and Hygiene | Plant-Produced Subunit Vaccine Candidates against Yellow Fever Induce...
The YF vaccines are considered safe and highly effective. However, a recent increase in demand for YF vaccines and reports of ... These results demonstrate partial protective efficacy in mice of YFE-based subunit vaccines expressed in N. benthamiana. ... All current licensed YF vaccines, including YF-Vax® (Sanofi-Pasteur, Lyon, France) and 17DD-YFV (Bio-Manguinhos, Rio de Janeiro ... Furthermore, these two YFE-based vaccine candidates induced VN antibody responses with high serum avidity in nonhuman primates ...
  http://www.ajtmh.org/content/journals/10.4269/ajtmh.16-0293
*  Effect of age at Vaccination on Immunological Response to Recombinant MAP Subunit Vaccine - DTU Orbit
Effect of age at Vaccination on Immunological Response to Recombinant MAP Subunit Vaccine: Abstract in journal. Publication: ... Thus an effective vaccine should not only elicit strong immune response in young animals, but also a quality of the T-cell ... Vaccine induced immune response, mainly the Th1 type cytokine secretion, was evaluated in different age groups following ... be interesting to determine the appropriate age of vaccination so as to generate the memory T cell pool and for MAP vaccine ...
  http://orbit.dtu.dk/en/publications/effect-of-age-at-vaccination-on-immunological-response-to-recombinant-map-subunit-vaccine
*  Subunit Protein Vaccines: Theoretical and Practical Considerations for HIV-1 | BenthamScience
Subunit Protein Vaccines: Theoretical and Practical Considerations for HIV-1. Author(s): Michael W. Cho. Case Western Reserve ... This review will be divided into three sections: First, the theoretical benefits and limitations of subunit protein vaccine ... This review will be divided into three sections: First, the theoretical benefits and limitations of subunit protein vaccine ... Keywords:Protein Vaccines, HIV-1, humoral immune responses. Abstract: With the spread of AIDS still rampant in many parts of ...
  http://www.eurekaselect.com/63866/article
*  Pigs immunized with a novel E2 subunit vaccine are protected from subgenotype heterologous classical swine fever virus...
Pigs immunized with a novel E2 subunit vaccine are protected from subgenotype heterologous classical swine fever virus ... The aim of this study is to develop a one-dose E2-subunit vaccine that can provide protection against CSFV challenge. We ... Our experimental vaccine KNB-E2 was formulated with the recombinant E2 protein (Genotype 1.1) expressed by insect cells and an ... CSF endemic countries have to use routine vaccination with modified live virus (MLV) vaccines to prevent and control CSF. ...
  https://www.physiciansweekly.com/pigs-immunized-with-a-novel-e2-subunit-vaccine-are-protected-from-subgenotype-heterologous-classical-swine-fever-virus-challenge/
*  JAIRO | Development of a selection marker-free rice-based oral cholera toxin B-subunit vaccine and determination of genomic...
Development of a selection marker-free rice-based oral cholera toxin B-subunit vaccine and determination of genomic location ... a whole genome resequencing approachDevelopment of a selection marker-free rice-based oral cholera toxin B-subunit vaccine and ...
  http://jairo.nii.ac.jp/0018/00016283/en
*  Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects - Tabular View -...
Individuals who had received any other vaccines within 2 weeks for inactivated vaccines or 4 weeks for live vaccines prior to ... Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects. This study has been ... Biological: Non-adjuvanted trivalent subunit influenza vaccine (TIV) one 0.5 mL dose administered IM in the deltoid muscle of ( ... Biological: MF59 adjuvanted trivalent subunit influenza vaccine (aTIV) one dose 0.5 mL administered IM in the deltoid muscle of ...
  https://clinicaltrials.gov/ct2/show/record/NCT01162122
*  Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children...
Biological: Cell culture-derived influenza subunit vaccine (cTIV) Biological: Egg derived influenza subunit vaccine (eTIV) ... Biological: Egg derived influenza subunit vaccine (eTIV) One 0.5 ml injection of the conventional egg-derived influenza vaccine ... Receipt of another vaccine within 2 weeks (for inactivated vaccines) or 4 weeks (for live vaccines) prior to Visit 1; ... Cell culture-derived influenza subunit vaccine (cTIV) One 0.5 ml injection of the cell culture-derived influenza vaccine in the ...
  https://clinicaltrials.gov/ct2/show/study/NCT00645411?show_locs=Y
*  Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 08/09 Season. - Full Text...
Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 08/09 Season.. The safety ... Biological: Trivalent influenza subunit vaccine Influvac 3x 15mcg HA per 0.5 ml, trivalent one injection at Day 1 ... Immunogenicity, Reactogenicity and Safety of the Trivalent Influenza Subunit Vaccine Influvac® for the Season 2008/2009. An ... and will be done to assess the immunogenicity and safety and tolerability of next season's trivalent influenza subunit vaccine ...
  https://clinicaltrials.gov/ct2/show/NCT00665509
*  Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2010/2011 Season
... therefore also the parts of viruses used in influenza vaccines can vary from y... ... To improve the efficacy of influenza vaccines, vaccine manufacturers h.... Universal influenza virus vaccines and therapeutics ... In the study Influvac will be compared to Agrippal, another subunit influenza vaccine that is already on the market in China. ... Home » Topics » Infectious-diseases » Research » Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New ...
  https://www.bioportfolio.com/resources/trial/63746/Annual-Study-to-Investigate-Inactivated-Subunit-Influenza-Vaccine-Due-to-New-Virus.html
*  Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-adjuvanted Inactivated...
inactivated subunit flu vaccine vs. inactivated subunit virus flu vaccine, with regards to A/H1N1 antigen, when administered to ... inactivated subunit flu vaccine vs. inactivated subunit virus flu vaccine, with regards to A/H3N2 antigen, when administered to ... inactivated subunit flu vaccine vs. inactivated subunit virus flu vaccine, with regards to B antigen, when administered to ... Keywords provided by Novartis ( Novartis Vaccines ): influenza. influenza vaccine. adjuvanted influenza vaccine. H5N1 influenza ...
  https://clinicaltrials.gov/ct2/show/NCT00519064?term=H1N1&rank=64
*  Novel Subunit Vaccines against Varicella Zoster Virus - Robert Whalen
Novel Subunit Vaccines against Varicella Zoster Virus Whalen, Robert Gerald Messaoudi, Ilhem Altravax, Inc., Sunnyvale, CA, ... Novel Subunit Vaccines against Varicella Zoster Virus. Whalen, Robert Gerald; Messaoudi, Ilhem / Altravax, Inc.. ... Novel Subunit Vaccines against Varicella Zoster Virus. Whalen, Robert Gerald; Messaoudi, Ilhem / Altravax, Inc.. ... the long-term efficacy of these live-attenuated vaccines is inadequate, and improved vaccines are desirable. Reactivation of ...
  http://grantome.com/grant/NIH/R43-AI112141-01
*  Subunit vaccine containing hemagglutinin or neuraminidase patent application class
Adjuvated Influenza Vaccine and Use Thereof - A viral vaccine, specifically an influenza vaccine, comprises a combination of a ... ADJUVANTED VACCINE FORMULATIONS - The invention relates to adjuvanted vaccine formulations, in particular influenza vaccines ... Two of more influenza vaccines are inoculated by a certain sequence, and each influenza vaccine vaccines is inoculated at least ... Subunit vaccine containing hemagglutinin or neuraminidase Subclass of:. 424 - Drug, bio-affecting and body treating ...
  http://www.patentsencyclopedia.com/class/000520543
*  Bacterial Recombination - BACTERIAL RECOMBINATION Purposes A Vaccine production(subunit type B Production of proteins(growth...
BACTERIAL RECOMBINATION Purposes A. Vaccine production (subunit type) B. Production of proteins (growth hormone) C. ... BACTERIAL RECOMBINATION Purposes A. Vaccine production (subunit type) B. Production of proteins (growth hormone) C. ...
  https://www.coursehero.com/file/6571838/Bacterial-Recombination/
*  Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine
a non-live combined RV - norovirus (NoV) vaccine candidate consisting of human RV inner-capsid rVP6 protein and NoV virus-like ... immunity, BALB/c mice were administered a vaccine containing RV rVP6 intramuscularly, intranasally or a combination of both, ... Live oral rotavirus (RV) vaccines are part of routine childhood immunization but are associated with adverse effects, ...
  http://tampub.uta.fi/handle/10024/99455
*  Development and pre-clinical assessment of a 73 kD chimeric fusion protein as a defined sub-unit vaccine for leprosy - GOV.UK
Development and pre-clinical assessment of a 73kD chimeric fusion protein as a defined sub-unit vaccine for leprosy. Vaccine ( ... Development and pre-clinical assessment of a 73 kD chimeric fusion protein as a defined sub-unit vaccine for leprosy ... Development and pre-clinical assessment of a 73 kD chimeric fusion protein as a defined sub-unit vaccine for leprosy ... A vaccine could overcome the inherent limitations of the drug treatment program by providing protection in individuals who are ...
  https://www.gov.uk/dfid-research-outputs/development-and-pre-clinical-assessment-of-a-73-kd-chimeric-fusion-protein-as-a-defined-sub-unit-vaccine-for-leprosy
*  USeq, MiSeq, WeAllSeq...to Seq: NIAID-DVI: Dengue subunit vaccine -- Beth-Ann Coller
Vaccine 28: 2705. There are several other subunit vaccines in development including one using NS1 which is mentioned in Murphy ... For an additional summary of current dengue vaccines out there...which includes numerous subunit vaccines see Wan et al., 2013 ... Labels: Beth-Ann Coller, dengue, Dengue Vaccine Initiative, Merck, NIAID-DVI, subunit vaccine ... The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease. Vaccine 29: ...
  http://weallseqtoseq.blogspot.com/2013/09/niaid-dvi-dengue-subunit-vaccine-beth.html